Clinical Cymru: Simbec Research buys Orion Clinical Services for £12.5m
Simbec Research has bought Orion Clinical Services in the latest deal backed by the Welsh Government’s £100m life sciences investment fund.
Archives for June 23, 2014
update
Ethanol diluent in injectables an intoxication risk says US FDA
The use of ethanol as a diluent in injectables is under the spotlight following a new US FDA warning that its presence in the cancer medicine docetaxel poses an intoxication risk.
SAFC to make virus-resistant cell lines
BioReliance and its parent company SAFC say they are working on viral-resistant cell lines that will prevent contamination in bioreactors.
Dispatches from BIO 2014
Kalon building $91m vaccine manufacturing facility in Texas for GSK partnership
Texas-based Kalon Biotherapeutics is in the process of building two new biomanufacturing facilities, including a $91m facility to produce flu vaccines for GlaxoSmithKline.
Copley develops new testing techs for generic respiratory drugs
Copley Scientific has launched new technologies to help developers of generic inhalable drugs stick to specific testing guidelines issued by the US FDA and USP.
Crown: improving animal irradiation can unlock failed drug candidates
The ability to pinpoint radiotherapy in animal testing could give failed cancer drug candidates a new lease of life, says preclinical CRO (contract research organisation) Crown Biosciences.